XORTX Therapeutics Inc (XRTX) — Financial Flexibility Index
XORTX Therapeutics Inc (XRTX) has a Financial Flexibility Index of -0.75x as of September 2025. Free cash flow of CA$-624.13K (operating CF CA$-629.62K minus capex CA$5.49K) represents -1% of total liabilities (CA$837.41K). Also explore XRTX net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
XORTX Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for XORTX Therapeutics Inc across 7 annual periods. Check how strategically is XORTX Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for XORTX Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for XORTX Therapeutics Inc. For the full company profile including market capitalisation, see XRTX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.80x | CA$-3.64 Million | CA$-3.68 Million | CA$757.99K | ▲ +39.3% |
| 2023 | -7.91x | CA$-6.54 Million | CA$-6.58 Million | CA$825.94K | ▼ -255.8% |
| 2022 | -2.22x | CA$-11.94 Million | CA$-11.97 Million | CA$5.37 Million | ▼ -95.2% |
| 2021 | -1.14x | CA$-6.04 Million | CA$-6.06 Million | CA$5.30 Million | ▼ -67.7% |
| 2020 | -0.68x | CA$-702.62K | CA$-728.40K | CA$1.03 Million | ▼ -294.5% |
| 2019 | -0.17x | CA$-223.80K | CA$-249.58K | CA$1.30 Million | ▲ +89.3% |
| 2018 | -1.60x | CA$-1.51 Million | CA$-1.56 Million | CA$943.70K | — |